The leukotriene receptor antagonist montelukast and aortic stenosis

被引：3
|
作者：
Back, Magnus [1 ,2 ]
Yin, Li [3 ]
Nagy, Edit [2 ]
Ingelsson, Erik [3 ]
机构：
[1] Karolinska Univ Hosp, Ctr Mol Med, Dept Cardiol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 75卷 / 01期
关键词：
DISEASE;
D O I：
10.1111/j.1365-2125.2012.04338.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [31] Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
    Leff, JA
    Busse, WW
    Pearlman, D
    Bronsky, EA
    Kemp, JA
    Hendeles, L
    Dockhorn, R
    Kundu, S
    Zhang, J
    Seidenberg, BC
    Reiss, TF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (03): : 147 - 152
  • [32] Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin-induced pulmonary fibrosis
    Topaloglu, Nurhayat
    Yildizeli, Sehnaz Olgun
    Sener, Goksel
    Lacin, Tunc
    Sehirli, Ozer
    Bozkurtlar, Emine
    Celikel, Cigdem
    Ceyhan, Berrin
    [J]. TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 26 (04): : 588 - 597
  • [33] Hepatic microsomal metabolism of montelukast, a potent leukotriene D-4 receptor antagonist, in humans
    Chiba, M
    Xu, X
    Nishime, JA
    Balani, SK
    Lin, JH
    [J]. DRUG METABOLISM AND DISPOSITION, 1997, 25 (09) : 1022 - 1031
  • [34] A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults
    Capella, GL
    Frigerio, E
    Altomare, G
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2001, 11 (03) : 209 - 213
  • [35] THERAPEUTIC EFFECT OF LEUKOTRIENE RECEPTOR ANTAGONIST MONTELUKAST IN TREATMENT OF RESPIRATORY TRACT MYCOPLASMAL INFECTIONS IN CHILDREN
    Chen, Peng
    Xiao, Fang
    Hu, Yanbing
    Ma, Zhongsen
    [J]. RESPIROLOGY, 2018, 23 : 178 - 179
  • [36] Effect of montelukast, a cysteinyl leukotriene receptor antagonist, on the progression of collagen-induced arthritis.
    Shiota, Naotaka
    Shimoura, Keiko
    Okunishi, Hideki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 166P - 166P
  • [37] Anti-inflammatory Properties of Montelukast, a Leukotriene Receptor Antagonist in Patients With Asthma and Nasal Polyposis
    Schaeper, C.
    Noga, O.
    Koch, B.
    Ewert, R.
    Felix, S. B.
    Glaeser, S.
    Kunkel, G.
    Gustavus, B.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2011, 21 (01) : 51 - 58
  • [38] Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
    Lipman, Marc C. I.
    Carding, Sally K.
    [J]. AIDS, 2007, 21 (03) : 383 - 384
  • [39] Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years
    Knorr, B
    Franchi, LM
    Bisgaard, H
    Vermeulen, JH
    LeSouef, P
    Santanello, N
    Michele, TM
    Reiss, TF
    Nguyen, HH
    Bratton, DL
    [J]. PEDIATRICS, 2001, 108 (03) : E48
  • [40] Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma
    Volovitz, B
    Tabachnik, E
    Nussinovitch, M
    Shtaif, B
    Blau, H
    Gil-Ad, I
    Weizman, A
    Varsano, I
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) : 1162 - 1167
12345